Covered recipient · General Payments record
MARIA TERESA VEGA-MARTINEZ
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$645.87
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $220.08 | 9 |
| Education | $45.10 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $81.25 | 3 |
| HARMONY BIOSCIENCES LLC | $70.10 | 2 |
| GENZYME CORPORATION | $48.13 | 2 |
| Mylan Specialty L.P. | $23.40 | 1 |
| Merck Sharp & Dohme Corporation | $22.30 | 1 |
| Acerta Pharma LLC | $20.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $20.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104416509 | CMS |
| GENZYME CORPORATION | $20.00 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139823135 | CMS |
| GENZYME CORPORATION | $28.13 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139823183 | CMS |
| GlaxoSmithKline, LLC. | $31.25 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116031008 | CMS |
| GlaxoSmithKline, LLC. | $25.00 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116433067 | CMS |
| GlaxoSmithKline, LLC. | $25.00 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116353550 | CMS |
| HARMONY BIOSCIENCES LLC | $25.00 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126088857 | CMS |
| HARMONY BIOSCIENCES LLC | $45.10 | 11/15/2024 | Education | Undisputed | 01/23/2026 | 1126088855 | CMS |
| Merck Sharp & Dohme LLC | $22.30 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141720234 | CMS |
| Mylan Specialty L.P. | $23.40 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147360478 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.